285 related articles for article (PubMed ID: 19302185)
1. Significance of antibodies to soluble liver antigen/liver pancreas: a large French study.
Eyraud V; Chazouilleres O; Ballot E; Corpechot C; Poupon R; Johanet C
Liver Int; 2009 Jul; 29(6):857-64. PubMed ID: 19302185
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
3. [The significance of anti-soluble liver antigen/liver-pancreas in diagnosing and typing autoimmune hepatitis].
Zhao Y; Yan HP; Tan YF; Feng X; Liu Y; Cui D; Ma DM; Li WH; Zhang HP
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):283-6. PubMed ID: 17456317
[TBL] [Abstract][Full Text] [Related]
4. [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis].
Bakker-Jonges LE; ter Borg PC; van Buuren HR; Hooijkaas H
Ned Tijdschr Geneeskd; 2006 Mar; 150(9):490-4. PubMed ID: 16553048
[TBL] [Abstract][Full Text] [Related]
5. [Presence of SLA/LP autoantibodies in patients with primary biliary cirrhosis as a marker for secondary autoimmune hepatitis (overlap syndrome)].
Kanzler S; Bozkurt S; Herkel J; Galle PR; Dienes HP; Lohse AW
Dtsch Med Wochenschr; 2001 Apr; 126(16):450-6. PubMed ID: 11360449
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.
Ma Y; Okamoto M; Thomas MG; Bogdanos DP; Lopes AR; Portmann B; Underhill J; Dürr R; Mieli-Vergani G; Vergani D
Hepatology; 2002 Mar; 35(3):658-64. PubMed ID: 11870381
[TBL] [Abstract][Full Text] [Related]
7. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
8. [Clinical and laboratory characteristics of anti-soluble liver antigen/liver-pancreas (SLA/LP) autoantibody positive liver disease patients].
Liu YM; Yan HP; Tan YF; Liu Y; Feng X; Kong SL
Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):927-9. PubMed ID: 16381642
[TBL] [Abstract][Full Text] [Related]
9. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies and their antigens in autoimmune hepatitis.
Bogdanos DP; Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to soluble liver antigen in patients with various liver diseases: a multicentre study.
Efe C; Ozaslan E; Wahlin S; Purnak T; Muratori L; Quarneti C; Yüksel O; Muratori P
Liver Int; 2013 Feb; 33(2):190-6. PubMed ID: 23295051
[TBL] [Abstract][Full Text] [Related]
12. Fine specificity of autoantibodies to soluble liver antigen and liver/pancreas.
Herkel J; Heidrich B; Nieraad N; Wies I; Rother M; Lohse AW
Hepatology; 2002 Feb; 35(2):403-8. PubMed ID: 11826415
[TBL] [Abstract][Full Text] [Related]
13. Anti-tRNP(ser)sec/SLA/LP autoantibodies. Comparative study using in-house ELISA with a recombinant 48.8 kDa protein, immunoblot, and analysis of immunoprecipitated RNAs.
Torres-Collado AX; Czaja AJ; Gelpí C
Liver Int; 2005 Apr; 25(2):410-9. PubMed ID: 15780067
[TBL] [Abstract][Full Text] [Related]
14. Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis.
Zachou K; Gampeta S; Gatselis NK; Oikonomou K; Goulis J; Manoussakis MN; Renaudineau Y; Bogdanos DP; Dalekos GN
Liver Int; 2015 Feb; 35(2):660-72. PubMed ID: 25113420
[TBL] [Abstract][Full Text] [Related]
15. Anti-soluble liver antigen/liver-pancreas (SLA/LP) antibodies in pediatric patients with autoimmune hepatitis.
Vitozzi S; Djilali-Saiah I; Lapierre P; Alvarez F
Autoimmunity; 2002 Dec; 35(8):485-92. PubMed ID: 12765473
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune hepatitis in children: what is different from adult AIH?
Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):297-306. PubMed ID: 19676002
[TBL] [Abstract][Full Text] [Related]
17. [The positive rate of auto antibodies and autoimmune liver diseases in patients with abnormal liver function].
Liu YM; Yan HP; Wang JT
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):360-2. PubMed ID: 15225434
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity to cytokeratin 8/18 in patients with soluble liver antigen (SLA) positive autoimmune hepatitis (AIH type 3) is not sufficient for diagnostic use.
Martin L; Bäurle A; Fiehn W; Volkmann M
Clin Lab; 2000; 46(7-8):339-44. PubMed ID: 10934580
[TBL] [Abstract][Full Text] [Related]
19. Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis.
Czaja AJ; Donaldson PT; Lohse AW
Am J Gastroenterol; 2002 Feb; 97(2):413-9. PubMed ID: 11866281
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]